In anticipation of this approval, Ziosoft recently established a European headquarters in Brussels, Belgium and has formed a number of strategic alliances with partners and distributors throughout Europe. CE marking approval is an important step in our strategy to broaden Ziosoft’s position in the international market, said Bart Hendriks, Ziosoft’s managing director for Europe, Middle East and Africa. We believe Europe will be a significant area of growth for Ziosoft’s thin-client advanced visualization software.

In 2008 Ziosoft entered the US market and has received a number of US Food and Drug Administration (FDA) clearances for its software applications. Ziosoft is also in the process of registering the Ziostation system in Canada in line with the company strategy to provide global access to Ziosoft’s innovative software solutions.